CML aims to be west’s biggest API maker with new plant
US group Cambridge Major Laboratories (CML) will begin transferring API production to its 125,000 sq ft manufacturing plant in Germantown, Wisconsin at the end of next month.
US group Cambridge Major Laboratories (CML) will begin transferring API production to its 125,000 sq ft manufacturing plant in Germantown, Wisconsin at the end of next month.
NextPharma Technologies’ development facility in Braine l’Alleud, Belgium has received positive early feedback following an inspection by the country’s drug watchdog, the AFMPS.
India’s Terrene Pharma has opened what it claims is the only gelatine capsule manufacturing plant in the country to be “designed from inception as per US FDA, EU EDQM and WHO GMP requirements.”